New York PostSig. 7NewsHealthLawPolitics
NYU Langone agreed to end transgender medical care for minors and pay $8.5 million to settle a DOJ investigation, becoming the latest hospital system to strike such a deal. The agreement spares NYU Langone from turning over medical records but shuts down its program, drawing criticism from NYC Mayor Zohran Mamdani and praise from DOJ officials.
The GuardianSig. 4NewsCultureHealth
Chad Gilbert, founding guitarist of New Found Glory, died at 45, his family announced. The article recounts his stage four cancer diagnosis and tributes from family and bandmates.
Daily MailSig. 6NewsHealth
A 57-year-old woman's severe aortic stenosis was repeatedly misdiagnosed as a virus, post-viral syndrome, or depression after six GP visits, until a stethoscope exam found a heart murmur. The article uses her case to warn that this dangerous heart valve condition is too often missed in women, delaying life-saving treatment.
Fox NewsSig. 6NewsElectionsCrimeHealth
An autism center run by Nimco Ahmed, a longtime friend of Minnesota Democratic Senate candidate Peggy Flanagan, is under investigation for Medicaid fraud and has been terminated from the program. The article ties the investigation to Flanagan's viral video appearance in a hijab defending the Somali community and notes social media criticism of Flanagan.
Washington ExaminerSig. 3NewsHealthPoliticsElections
Illinois Gov. JB Pritzker disclosed that he lost 80 pounds using a GLP-1 drug and discussed his diabetes and personal health journey. The article also notes his potential 2028 presidential ambitions, Trump's past insults about his weight, and his stated focus on serving as governor.
CBS NewsSig. 3NewsPoliticsHealth
Illinois Gov. JB Pritzker discussed his two-year GLP-1 use, 80-pound weight loss, and diabetes diagnosis in an interview. He deflected a question about a 2028 presidential run while promoting Illinois' decision to cover GLP-1s for state employees.
PoliticoSig. 5NewsPoliticsHealthElections
Illinois Gov. JB Pritzker disclosed that he was diagnosed with Type 2 diabetes two years ago and lost 80 pounds after starting a GLP-1 medication, saying he is no longer on insulin. He discussed his health transformation, Illinois’ coverage of GLP-1 medications, and sidestepped questions about a 2028 presidential run.
Washington ExaminerSig. 7NewsHealthSciencePolitics
The Department of Health and Human Services and its agencies announced new programs and an FDA rule to reduce animal testing in biomedical research, shifting toward human organoids, artificial intelligence, and computational models. The article presents the Trump administration and HHS Secretary Robert F. Kennedy Jr. as modernizing federal research and advancing U.S. biopharmaceutical competitiveness.
Washington ExaminerSig. 6OpinionHealthMediaPolitics
A former cardiothoracic surgeon and congressman defends the U.S. organ donation and transplantation system against what he calls dangerous misinformation. He argues that false claims about organ procurement organizations are illegal and could cause thousands to leave donor registries, threatening a regulated system that saves lives.
Washington ExaminerSig. 8OpinionHealthLawPolitics
The article argues that the FDA has long delayed safety scrutiny of mifepristone and is trying to avoid judicial review of its loosened REMS while pro-life states like Louisiana challenge the rules. It contends the 5th Circuit should let pro-life states sue and rule in their favor.
The GuardianSig. 3NewsHealthOther
A woman went into labor while stuck in heavy San Francisco traffic near Golden Gate Park and gave birth to a healthy baby girl. A passing doula helped the couple after first responders were also delayed by congestion and arrived on foot. The mother and child were transported to a hospital in good condition.
Washington ExaminerSig. 6OpinionEnergyHealthForeign
The op-ed argues the U.S. should expand domestic production of medical and industrial radioisotopes to avoid dependence on Russia, China, and other foreign suppliers. It points to a new Oklo test reactor in Texas as evidence that streamlined nuclear development can rebuild capacity. It urges regulatory reform while maintaining safety standards.